Stock price Celgene Corp (CELG) today

Celgene Corporation is an American international biopharmaceutical company engaged in the search, development and sale of drugs for cancer and inflammatory diseases. It was founded in New Jersey in 1986 as a division of Celanese Corporation. After merging with Hoechst Corporation, it was established as an independent company and began to buy private biotherapeutic companies such as Signal Pharmaceuticals and Anthrogenesis. In addition, Celgene collaborated with Astrazeneca and Agios Pharmaceuticals, developers of new products for the immune system. In 2018 and 2019, Impact Biomedicines were announced to purchase $ 7 billion, Juno Therapeutics for $ 9 billion, and the merger with Bristol-Myers Squibb for $ 74 billion. To date, the market capitalization of Calgene is estimated at 51.8 billion dollars.